Elementy, w których Ms. Imaan Kherani uczestniczy
piątek 10 czerwiec, 2022
Authors: Imaan Z. Kherani, Julia Farah, Rajinder Nirwan, Natalia Figueiredo, Anna Ells, Michael Fielden, R. Geoff Williams, Amin Kherani, Olga Ziozina.Author Disclosure Block: I.Z. Kherani: None. J. Farah: None. R. Nirwan: None. N. Figueiredo: None. A. Ells: None. M. Fielden: None. R. Williams: Membership on advisory boards or speakers’ bureaus; Name of for-profit or not-for-profit organization(s); Bayer, Novartis, Roche. Funded grants or clinical ...
sobota 11 czerwiec, 2022
Authors: Imaan Z. Kherani1, Chad Andrews2, Jennifer Pereira3, Larissa Moniz4, Cynthia X. Qian5. 1Temerty Faculty of Medicine, University of Toronto, 2College of Optometrists of Ontario, 3JRL Research & Consulting Inc., 4Fighting Blindness Canada, 5Department of Ophthalmology, Universite de Montreal.Author Disclosure Block: I.Z. Kherani: None. C. Andrews: Any direct financial payments including receipt of honoraria; Name of for-profit or not-for-profit organization(s); Fighting Blin...
czwartek 15 czerwiec, 2023
piątek 16 czerwiec, 2023
Authors: Imaan Z. Kherani, Daiana R. Pur , Nupura K. Bakshi Author Disclosures: I.Z. Kherani: None. D.R. Pur: None. N.K. Bakshi: Any direct financial payments including receipt of honoraria; Name of for-profit or not-for-profit organization(s); Bayer, Novartis, Biogen, Roche, Teva. Any direct financial payments including receipt of honorar...